Tag: Human Insulin Market

Can Walmart’s “Affordable” Insulin Enhance Insulin Accessibility in the USA?

Amongst 30 million Americans diagnosed with diabetes, about 1.4 million Type-1 Diabetes patients require insulin lifelong to manage their condition, but affordability is a great concern. Insulin prices have increased up to 1200% since 1996, even though the formulations have largely remained the same. The cost of insulin is ten times more in the USA than in any other developed country.

United States Human Insulin Market to Grow with Increasing Diabetics until 2026 | TechSci Research

Surge in diabetic patients is driving the growth of United States Human Insulin Market, in the forecast period. According to TechSci report on, “United States Human Insulin Market By Indication (Type 1 Diabetes v/s Type 2 Diabetes) By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection) By Type (Basal, Bolus, Pre-Mixed, Biosimilar, Traditional) By Onset Time

Human Insulin Market to Grow to be Valued USD 43.33 Billion by 2025

Growing diabetic population to drive global human insulin market during forecast period According to TechSci Research report, “Global Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Transdermal, Nasal, Intravenous, Oral and Others), By Type (Basal, Bolus, Pre-mixed,

Human Insulin Market to Grow at a Steady CAGR until 2025

Growing diabetic population to drive global human insulin market during forecast period According to TechSci Research report, “Global Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Brand (Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Nasal, Intravenous, Oral and Others), By Type (Basal, Bolus,